Ignite Creation Date:
2024-05-05 @ 11:21 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00002399
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
1999-11-02
Brief Title:
A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis OPC in HIV-Positive Patients
Sponsor:
Schering-Plough
Organization:
NIH AIDS Clinical Trials Information Service
Study Overview
Official Title:
A Multicenter Randomized Double-Blind Phase II Study to Evaluate the Safety Tolerance and Efficacy of Multiple Doses of SCH 56592 Versus Fluconazole in the Treatment of Oropharyngeal Candidiasis OPC in HIV-Positive Patients
Status:
COMPLETED
Status Verified Date:
1999-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to compare the safety and effectiveness of SCH 56592 with that of fluconazole in the treatment of OPC a fungal infection of the throat in HIV-positive patients
Detailed Description:
This is a randomized multicenter double-blind study consisting of 5 arms 4 dose levels of SCH 56592 vs fluconazole in the treatment of oropharyngeal candidiasis OPC in HIV-positive patients
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| I96-209 | None | None | None |
| C96-209 | None | None | None |